Skip to main content
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
35.08
+1.89 (5.69%)
At close: Mar 9, 2026, 4:00 PM EDT
35.08
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

IDEAYA Biosciences Revenue

In the year 2025, IDEAYA Biosciences had annual revenue of $218.71M with 3,024.43% growth. IDEAYA Biosciences had revenue of $10.88M in the quarter ending December 31, 2025, with 55.37% growth.

Revenue (ttm)
$218.71M
Revenue Growth
+3,024.43%
P/S Ratio
13.88
Revenue / Employee
$1,508,345
Employees
145
Market Cap
3.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025218.71M211.71M3,024.43%
Dec 31, 20247.00M-16.39M-70.07%
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Catalyst Pharmaceuticals 588.99M
Tarsus Pharmaceuticals 451.36M
Arcutis Biotherapeutics 376.07M
Arcus Biosciences 247.00M
Beam Therapeutics 139.74M
Viridian Therapeutics 70.85M
Dianthus Therapeutics 3.08M
Revenue Rankings

IDYA News

More News